Search Results
Aug 27, 2025, 06:30 ET Global CAR-T Cell Therapy Market to Hit $217.6Bn by 2035 at 39.75% CAGR | Vantage Market Research
Deoxyribonucleic Acid (DNA) Vaccines Market by Types (Human DNA Vaccines, Animal DNA Vaccines), by Application (Human diseases, Veterinary Diseases , Allergies and Others), by Region (North
More news about: Vantage Market Research
Aug 26, 2025, 23:41 ET Winning the 2025 Paris DNA Design Award, AIMA's Santa Monica Electric Bike Empowers E-bike Upgrade
PARIS, Aug. 26, 2025 /PRNewswire/ -- Recently, the 2025 Paris DNA Design Awards announced its winners list. The Santa Monica electric bike, an E-bike model from AIMA TECHNOLOGY GROUP CO.,LTD., a leading electric two-wheeler
More news about: AIMA Technology
Aug 26, 2025, 14:00 ET BetMGM Unveils First Major Corporate Brand Repositioning with "Make it Legendary" Campaign
BetMGM stands for. We're at the forefront of entertainment and gaming, with the spirit of Las Vegas woven into our DNA," said Casey Hurbis, Chief Marketing Officer, BetMGM. "Our new positioning celebrates the thrill, spectacle and storytelling
More news about: BetMGM
Aug 26, 2025, 13:46 ET BillionToOne's Northstar Select® Demonstrates Superior Sensitivity in Prospective Head-to-Head Validation Study Publication
genomic profiling (CGP) liquid biopsy assay, demonstrating superior performance in detecting more clinically actionable alterations in circulating tumor DNA (ctDNA).
More news about: BillionToOne
Aug 26, 2025, 11:00 ET Hemi Raises $15 Million to Accelerate Bitcoin Programmability Ahead of Token Launch
Crypto.com, DNA Fund, Selini Capital,
More news about: Hemi
Aug 26, 2025, 10:00 ET High-Precision Base Editing Clinical Treatment for Sickle Cell Disease -- CorrectSequence Therapeutics' CS-101 Achieves Promising Results in First Patient
therapies, CS-101 delivers efficient hematopoietic recovery and higher HbF-to-HbS ratio, without the risks of large DNA deletions, chromosomal rearrangements, or off-target mutations. To date, CS-101 has been used to treat nearly 20 patients with β-thalassemia or
More news about: CorrectSequence Therapeutics
Aug 26, 2025, 08:05 ET INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults
About INOVIO's DNA Medicines PlatformINOVIO's DNA medicines platform has two innovative components: precisely designed DNA plasmids, delivered by INOVIO's proprietary investigational medical device, CELLECTRA. INOVIO uses proprietary technology to design its DNA plasmids, which are
More news about: INOVIO Pharmaceuticals, Inc.
Aug 26, 2025, 08:01 ET PAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging Technology
Diagnostics Inc. (NASDAQ: LUCD), is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard® Esophageal DNA Test and EsoCheck® Esophageal Cell Collection Device—the first and only commercial tools for widespread early detection of esophageal precancer
More news about: PAVmed Inc.
Aug 26, 2025, 08:00 ET zvoove Acquires CleanManager: Accelerating Growth by entering the Nordics and enhancing Cleaning Software Portfolio
also positions us in the Nordic region - a dynamic, innovation-driven market with a robust ecosystem that aligns perfectly with our entrepreneurial DNA," says Oliver Muhr, CEO of zvoove. CleanManager is a trusted solution across Denmark,
More news about: zvoove
Aug 26, 2025, 08:00 ET zvoove akquiriert CleanManager: Expansion von zvoove Clean durch Markteintritt in Skandinavien
positioniert uns auch in Skandinavien – einem dynamischen, innovationsorientierten Markt mit einem robusten Ökosystem, das perfekt zu unserer unternehmerischen DNA passt." CleanManager ist eine etablierte Lösung in Dänemark, Deutschland und Großbritannien und bietet leistungsstarke, zugleich benutzerfreundliche
More news about: zvoove
Aug 26, 2025, 08:00 ET zvoove Acquires CleanManager: Accelerating Growth by entering the Nordics and enhancing Cleaning Software Portfolio
also positions us in the Nordic region - a dynamic, innovation-driven market with a robust ecosystem that aligns perfectly with our entrepreneurial DNA," says Oliver Muhr, CEO of zvoove. CleanManager is a trusted solution across Denmark,
More news about: zvoove
Aug 26, 2025, 08:00 ET zvoove opkøber CleanManager: Sætter fart på væksten ved at træde ind i Norden og styrker porteføljen af software til rengøringsbranchen
også en stærk tilstedeværelse i Norden – et dynamisk og innovationsdrevet marked med et solidt erhvervsmiljø, der passer perfekt til vores iværksætter DNA," siger Oliver Muhr, CEO for zvoove. CleanManager er en anerkendt og udbredt løsning i Danmark, Tyskland og Storbritannien.
More news about: zvoove
Aug 26, 2025, 08:00 ET zvoove neemt CleanManager over: snellere groei dankzij toegang tot de Scandinavische markt en uitbreiding van de softwareportfolio voor schoonmaak
maar positioneert ons ook in Scandinavië - een dynamische, door innovatie gedreven markt met een robuust ecosysteem dat perfect aansluit bij ons ondernemers-DNA," verklaart Oliver Muhr, CEO van zvoove. CleanManager is een vertrouwde oplossing in Denemarken, Duitsland
More news about: zvoove
Aug 26, 2025, 07:30 ET PackGene to Offer Barcoded High-Throughput AAV Capsid Screening Kits Through Strategic License Agreement with Children's Medical Research Institute
work of establishing barcoded AAV capsid kits, which allow for NGS-based parallel evaluation of large numbers of AAVs for their performance at both DNA (proxy for cell entry) and RNA (proxy for transgene expression) levels to allow fast, precise and high-throughput identification of the most functional
More news about: Packgene
Aug 26, 2025, 04:00 ET High-Precision Base Editing Clinical Treatment for Sickle Cell Disease -- CorrectSequence Therapeutics' CS-101 Achieves Promising Results in First Patient
with conventional CRISPR/Cas9-based therapies, CS-101 delivers efficient hematopoietic recovery and higher HbF-to-HbS ratio, without the risks of large DNA deletions, chromosomal rearrangements, or off-target mutations. To date, CS-101 has been used to treat nearly 20 patients with β-thalassemia or
More news about: CorrectSequence Therapeutics
Aug 26, 2025, 02:00 ET High-Precision Base Editing Clinical Treatment for Sickle Cell Disease -- CorrectSequence Therapeutics' CS-101 Achieves Promising Results in First Patient
with conventional CRISPR/Cas9-based therapies, CS-101 delivers efficient hematopoietic recovery and higher HbF-to-HbS ratio, without the risks of large DNA deletions, chromosomal rearrangements, or off-target mutations. To date, CS-101 has been used to treat nearly 20 patients with β-thalassemia or
More news about: CorrectSequence Therapeutics
Aug 25, 2025, 10:37 ET From Job Sites to Tour Stops: DECKED Partners with CBS' New Music Competition Show, The Road
musicians pile into a tour bus and tackle a grueling schedule in pursuit of their dreams. "Supporting hard-working, road-tested people is in our DNA," said Greg Randolph, vice president of Marketing at DECKED. "The traveling musicians in The Road live out of their
More news about: DECKED
Aug 25, 2025, 10:01 ET Single Cell Sequencing Market worth $3.46 billion by 2030 with 12.2% CAGR | MarketsandMarkets™
research. By sequencing type, the single-cell sequencing market is divided into single-cell transcriptome (RNA) sequencing, single-cell genome (DNA) sequencing, single-cell ATAC sequencing, and other single-cell sequencing techniques. In 2024, single-cell transcriptome sequencing held the largest
More news about: MarketsandMarkets
Aug 25, 2025, 10:00 ET Deloitte recognized as a Leader and a Star Performer in Everest Group's Financial Crime and Compliance Operations Services PEAK Matrix® Assessment 2025
were distinguishing features of its capability advancements. Everest Group's report also highlighted Deloitte's strong advisory and regulatory DNA—with ex-regulators and law enforcement practitioners embedded in its teams—in addition to its integration of AI/GenAI capabilities into Deloitte's Enterprise
More news about: Deloitte
Aug 25, 2025, 08:55 ET FYZICAL Therapy & Balance Centers Rallies Clinics Nationwide to "Fight the Fall" This September
and far too often, their quality of life. At FYZICAL, preventing these tragedies isn't just something we talk about once a year; it's woven into our DNA. Fight the Fall is our chance to come together as a nationwide team and shine a spotlight on the life-changing work we do every day," said Rick
More news about: FYZICAL Therapy & Balance Centers
Aug 25, 2025, 08:52 ET FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics
specific liquid biopsy test designed by cancer genomic pioneers and liquid biopsy experts to uncover low levels of circulating-tumor DNA (ctDNA)—tiny fragments of DNA in the bloodstream that originate from tumor cancer cells that can signify residual, recurrent, or resistant disease in patients diagnosed
More news about: Quest Diagnostics
Aug 25, 2025, 08:05 ET INOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting
More news about: INOVIO Pharmaceuticals, Inc.
Aug 25, 2025, 05:10 ET Bybit Unveils 1H 2025 Report: A Masterclass in Crisis Response, AI-Driven Innovation, and Market Leadership
broader adoption for the crypto industry. We are committed to being a leading force in rewriting security and industry standards—co-building is in our DNA. Download the Full Report
More news about: Bybit
Aug 25, 2025, 04:55 ET Bybit Unveils 1H 2025 Report: A Masterclass in Crisis Response, AI-Driven Innovation, and Market Leadership
adoption for the crypto industry. We are committed to being a leading force in rewriting security and industry standards—co-building is in our DNA. Download the Full Report
More news about: Bybit
Aug 25, 2025, 03:37 ET Valmet to deliver an IntelliTissue 1600 machine to PT Suparma Tbk in Indonesia
IntelliPress, IntelliYankee dryer, Exhaust Cap hood, and an IntelliReel section. The scope also includes mechanical and electrical drives, Valmet DNA system with Machine Control System, Distributed Control System and Quality Control System, dust removal system, and auxiliary systems for the tissue
More news about: Valmet Oyj